Michael William Pennington
Direttore Tecnico/Scientifico/R&S presso Ambio Pharmaceuticals
Posizioni attive di Michael William Pennington
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Direttore Tecnico/Scientifico/R&S | 16/06/2021 | - |
AmbioPharm, Inc. (South Carolina)
 AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Direttore Tecnico/Scientifico/R&S | 04/03/2019 | - |
| Vendite & Marketing | 16/02/2018 | 04/03/2019 |
Storia della carriera di Michael William Pennington
Precedenti posizioni note di Michael William Pennington
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Peptides International LLC
 Peptides International LLC BiotechnologyHealth Technology Peptides International, Inc. manufactures and distributes biochemical products. It engages in research and development that complements the production of solid phase resins, amino acid derivatives, peptides, and related products. The company was founded by Arno. F. Spatola in 1983 and is headquartered in Louisville, KY. | Amministratore Delegato | 01/10/2012 | 01/02/2018 |
| Direttore Tecnico/Scientifico/R&S | 01/12/2010 | 01/10/2012 | |
| Bachem Bioscience, Inc. | Direttore operativo | 01/07/2000 | 01/08/2010 |
| Direttore Tecnico/Scientifico/R&S | 01/12/1992 | 01/07/2000 |
Formazione di Michael William Pennington
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| University of Florida | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Isole Cayman | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Chief Executive Officer | 1 |
| Sales & Marketing | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Peptides International LLC
Peptides International LLC BiotechnologyHealth Technology Peptides International, Inc. manufactures and distributes biochemical products. It engages in research and development that complements the production of solid phase resins, amino acid derivatives, peptides, and related products. The company was founded by Arno. F. Spatola in 1983 and is headquartered in Louisville, KY. | Health Technology |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Commercial Services |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Health Technology |
| Bachem Bioscience, Inc. |